FN2 Earnings Intelligence
Incyte Corporation ratios (quarterly)
Incyte Corporation (INCY) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $1,941.7 | $1,955 | $2,455 | $3,461.1 | $3,982.4 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $1,052.9 | $1,215.5 | $1,366 | $1,272.7 | $1,674 | $1,466.5 | $1,531.6 |
| % Growth | - | - | - | - | - | 7.4% | - |
| Gross Profit | $979.7 | $1,136.8 | $1,267 | $1,168.2 | $1,569.1 | - | - |
| % Margin | 93.0% | 93.5% | 92.8% | 91.8% | 93.7% | - | - |
| EBITDA | $227.5 | - | - | $324.9 | - | - | - |
| % Margin | 21.6% | - | - | 25.5% | - | - | - |
| Net Income | $158.2 | $405 | $424.2 | $303.3 | $585.6 | - | - |
| % Margin | 15.0% | 33.3% | 31.1% | 23.8% | 35.0% | - | - |
| Diluted EPS | $0.80 | $2.04 | $2.11 | $1.47 | $2.81 | -$1.59 | $1.99 |
| % Growth | - | - | - | - | - | -175.2% | - |
| Operating Cash Flow | $266.1 | - | - | $369.4 | - | - | - |
| CapEx | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $1,052.9 | $1,215.5 | $1,366 | $1,272.7 | $1,674 | $1,466.5 | $1,531.6 |
| Gross Profit | $979.7 | $1,136.8 | $1,267 | $1,168.2 | $1,569.1 | - | - |
| EBITDA | $227.5 | - | - | $324.9 | - | - | - |
| Net Income | $158.2 | $405 | $424.2 | $303.3 | $585.6 | - | - |
| Diluted EPS | $0.80 | $2.04 | $2.11 | $1.47 | $2.81 | -$1.59 | $1.99 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1,941.7 | $1,955 | $2,455 | $3,461.1 | $3,982.4 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $266.1 | - | - | $369.4 | - |
| Capital Expenditure | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 93.0% | 93.5% | 92.8% | 91.8% | 93.7% |
| EBITDA Margin | 21.6% | - | - | 25.5% | - |
| Net Margin | 15.0% | 33.3% | 31.1% | 23.8% | 35.0% |
| FCF Margin | - | - | - | - | - |
| Diluted EPS Growth | - | - | - | - | - |